Short and long-term renal transplant complications
How to work up a rising creatinine after kidney transplant step by step, delayed graft function, rejection on Banff biopsy and its treatment, BK nephropathy, diarrhoea and neutropenia on immunosuppression, and the long-term burden of cancer, cardiovascular disease, post-transplant diabetes and recurrent disease.
Tier 2Medical sciences concept
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- The timeline organises the complications: surgical problems in the first weeks, rejection and opportunistic infection in the first year, then cancer, cardiovascular disease, metabolic disease and chronic graft injury for life.
- A rise in creatinine is the commonest problem a registrar sees. Graft rejection is usually silent, and creatinine is a late marker, so even a 15 to 20% rise deserves a structured work-up.
- The most frequent cause of graft loss is death with a functioning graft. Cancer and cardiovascular disease are the main killers.
Loading the rest of the note…
Finished reading?
Sources
- KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Am J Transplant 2009;9 Suppl 3:S1-155Kidney Disease Improving Global Outcomes, 2009 (still the current KDIGO version, checked November 2026)
- KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant RecipientsAU/NZKHA-CARI, 2012
- Naesens M et al. The Banff 2024 Kidney Meeting Report: rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning. Am J Transplant 2026;26(5):922-36American Journal of Transplantation, 2026 (Banff 2024 meeting; no classification changes from Banff 2022)
- Kotton CN, Kamar N, Wojciechowski D et al. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation. Transplantation 2024;108:1834-66The Transplantation Society, 2024
- Kotton CN et al. The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation. Transplantation 2025;109(7):1066-110The Transplantation Society, 2025
- Sharif A et al. International consensus on post-transplantation diabetes mellitus. Nephrol Dial Transplant 2024;39(3):531-49Nephrology Dialysis Transplantation, 2024 (replaces the 2014 consensus)
- Limaye AP et al. Letermovir vs valganciclovir for prophylaxis of cytomegalovirus in high-risk kidney transplant recipients: a randomized clinical trial. JAMA 2023;330:33-42JAMA, 2023
- ANZDATA Registry 48th Annual Report 2025, chapter 7 (Kidney Transplantation)AU/NZAustralia and New Zealand Dialysis and Transplant Registry, 2025
- Antibiotic and Gastrointestinal (Therapeutic Guidelines)AU/NZTherapeutic Guidelines Ltd
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback